[1]王小蕊,李文倩,解友邦,等.托法替尼联合传统DMARDs类药物治疗类风湿性关节炎临床效果观察[J].陕西医学杂志,2023,52(12):1728-1730.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]
　WANG Xiaorui,LI Wenqian,XIE Youbang,et al.Clinical effect of tofacitinib combined with traditional DMARDs in treatment of rheumatoid arthritis[J].,2023,52(12):1728-1730.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]
点击复制

托法替尼联合传统DMARDs类药物治疗类风湿性关节炎临床效果观察
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年12期
页码:
1728-1730
栏目:
药物与临床
出版日期:
2023-12-05

文章信息/Info

Title:
Clinical effect of tofacitinib combined with traditional DMARDs in treatment of rheumatoid arthritis
作者:
王小蕊; 李文倩; 解友邦; 杨红艳
(青海省人民医院血液风湿免疫科,青海 西宁 810001)
Author(s):
WANG Xiaorui; LI Wenqian; XIE Youbang; YANG Hongyan
(Department of Rheumatology and Immunology,Qinghai Provincial People's Hospital,Xining 810001,China)
关键词:
类风湿关节炎;  托法替尼;  传统改善病情抗风湿药;  免疫功能;  安全性;  炎症反应
Keywords:
Rheumatoid arthritis;  Tofacitinib;  Traditional disease modifying anti-rheumatic drugs;  Immune function;  Safety;  Inflammatory response
分类号:
R 593.22
DOI:
DOI:10.3969/j.issn.1000-7377.2023.12.022
文献标志码:
A
摘要:
目的:探讨托法替尼联合传统改善病情抗风湿药(DMARDs)类药物治疗类风湿关节炎的临床效果。方法:选择类风湿关节炎患者78例,随机分为观察组与对照组,各39例。对照组采用传统DMARDs类药物治疗,观察组在对照组基础上采用托法替尼治疗。两组治疗时间均为3个月。比较两组病情活动度、关节恢复情况、炎症反应、免疫功能及不良反应。结果:治疗后,两组类风湿性关节炎病情活动度评价标准(DAS28)评分降低,且观察组更低(均P<0.05); 两组关节肿胀数、关节触痛数降低,且观察组更低(均P<0.05); 两组晨僵时间缩短,且观察组更短(均P<0.05); 两组血清白细胞介素-10(IL-10)、干扰素-γ(IFN-γ)、IL-12水平降低,且观察组更低(均P<0.05); 两组血清IL-4、IL-2水平升高,且观察组更高(均P<0.05); 两组CD3+、CD4+、CD19+细胞水平升高,且观察组更高(均P<0.05); 两组CD8+细胞水平、血清免疫球蛋白G(IgG)水平降低,且观察组更低(均P<0.05)。结论:托法替尼联合传统DMARDs类药物治疗类风湿关节炎的临床效果确切,可改善患者疾病活动度、临床症状,减轻炎症反应,改善免疫功能,且安全性良好。
Abstract:
Objective:To investigate the clinical effect of tofacitinib combined with traditional anti-rheumatic drugs(DMARDs)in the treatment of rheumatoid arthritis.Methods:78 patients with rheumatoid arthritis were randomly divided into observation group and control group,39 cases in each group.The control group was treated with traditional DMARDs,and the observation group was treated with tofacitinib based on the control group.Both groups were treated for 3 months.Disease activity,joint recovery,inflammation,immune function and adverse reactions were compared between the two groups.Results:After treatment,the DAS28 score of rheumatoid arthritis was lower in both groups,and lower in the observation group(all P<0.05); the number of joint swelling and tenderness in both groups were decreased,and the observation group was lower(all P<0.05); the morning rigor time of the two groups was shortened,and the observation group was shorter(all P<0.05); serum levels of IL-10,IFN-γ and IL-12 in two groups were decreased,and those in observation group were lower(all P<0.05); serum IL-4 and IL-2 levels were increased in both groups,and those in observation group were higher(all P<0.05); the levels of CD3+,CD4+ and CD19+ cells in two groups were increased,and the levels in observation group were higher(all P<0.05); the levels of CD8+ cells and serum IgG were decreased in both groups,and were lower in the observation group(all P<0.05).Conclusion:Tofacitinib combined with traditional DMARDs has a definite clinical effect in the treatment of rheumatoid arthritis,which can improve disease activity,clinical symptoms,reduce inflammatory response,improve immune function,and has good safety.

参考文献/References:

[1] Lin YJ,Anzaghe M,Schulke S.Update on the pathomechanism,diagnosis,and treatment options for rheumatoid Arthritis[J].Cells,2020,9(4):880.
[2] 封小川,李利霞.肌肉骨骼超声检查在跖趾类风湿关节炎与痛风性关节炎骨侵蚀鉴别诊断中的临床意义[J].陕西医学杂志,2021,50(7):833-835.
[3] Dai Y,Wang W,Yu Y,et al.Rheumatoid arthritis-associated interstitial lung disease:An overview of epidemiology,pathogenesis and management[J].Clin Rheumatol,2021,40(4):1211-1220.
[4] 倪丹红,刘 丹,吕琴琴,等.秦息痛片联合传统抗风湿药治疗早期活动性类风湿关节炎临床研究[J].陕西中医,2019,40(4):484-486.
[5] 常 岑,张润润,时一鸣,等.中医疗法治疗类风湿性关节炎的研究进展[J].中国中药杂志,2023,48(2):329-335.
[6] Kadura S,Raghu G.Rheumatoid arthritis-interstitial lung disease:Manifestations and current concepts in pathogenesis and management[J].Eur Respir Rev,2021,30(160):210011.
[7] 罗红敏.托法替尼治疗类风湿关节炎的心血管事件和癌症风险[J].中华危重病急救医学,2022,34(4):406.
[8] 中华医学会风湿病学分会.类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270.
[9] 李世琴,李亚玲,黄毅岚,等.选择性Janus激酶1抑制药Upadacitinib和Filgotinib治疗类风湿性关节炎疗效和安全性的Meta分析[J].中国药房,2019,30(15):2130-2135.
[10] Mueller AL,Payandeh Z,Mohammadkhani N,et al.Recent advances in understanding the pathogenesis of rheumatoid arthritis:New treatment strategies[J].Cells,2021,10(11):3017.
[11] Forsyth C,Kouvari M,Dcunha NM,et al.The effects of the mediterranean diet on rheumatoid arthritis prevention and treatment:A systematic review of human prospective studies[J].Rheumatol Int,2018,38(5):737-747.
[12] Wu CY,Yang HY,Lai JH.Anti-citrullinated protein antibodies in patients with rheumatoid arthritis:Biological effects and mechanisms of immunopathogenesis[J].Int J Mol Sci,2020,21(11):4015.
[13] 罗红敏.托法替尼治疗类风湿关节炎的心血管事件和癌症风险:一项随机临床试验[J].中华危重病急救医学,2022,34(1):27.
[14] 郭淑芳,姜婷婷.下调miR-217抑制类风湿性关节炎患者外周血单个核细胞炎症反应的实验研究[J].中国免疫学杂志,2020,36(8):933-938.
[15] 徐连那,李旭艳,庞琳娜,等.甲氨蝶呤联合来氟米特治疗类风湿性关节炎对血清疼痛介质以及Th1/Th2型细胞因子的影响[J].热带医学杂志,2022,22(7):983-986,1009.
[16] 李 玲,李作孝.托法替尼对大鼠实验性自身免疫性脑脊髓炎的抑制作用及其机制[J].医药导报,2020,39(7):900-904.
[17] 孙思东,边祥涛.穴位贴敷辅助五味消毒饮对类风湿性关节炎患者免疫功能、Th17/Tregs平衡的影响[J].中国医院用药评价与分析,2022,22(3):293-296.
[18] 刘 茜,张翊一,李映雪,等.川羌除痹汤联合西药对类风湿性关节炎患者免疫功能及Th1/Th2型细胞因子的影响[J].陕西中医,2019,40(12):1732-1735.
[19] 嵇 辉,杨增敏,陈其义.桂枝芍药知母汤对类风湿性关节炎患者实验室指标和免疫功能的影响[J].世界中医药,2020,15(20):3097-3100.
[20] 杨文芳,莫薇薇,韩海思,等.壮医火针疗法结合中药离子导入对类风湿性关节炎患者临床症候、免疫功能和外周血象的影响[J].四川中医,2021,39(9):191-194.
[21] Hodge JA,Kawabata TT,Krishnaswami S,et al.The mechanism of action of tofacitinib:An oral Janus kinase inhibitor for the treatment of rheumatoid arthritis[J].Clin Exp Rheumatol,2016,34(2):318-328.

相似文献/References:

[1]卢北玲,史剑飞,彭 晶,等.CRP、RF及ASO检测在类风湿关节炎合并肺间质纤维化诊断中的价值[J].陕西医学杂志,2019,(6):803.
[2]孙芳芳,张 静△,范秀风.类风湿关节炎合并心血管损伤危险因素研究*[J].陕西医学杂志,2019,(10):1305.
[3]王 颖,白 琳,张 洁,等.抑制炎性细胞因子与类风湿关节炎合并急性心肌梗死患者颈动脉斑块相关性研究*[J].陕西医学杂志,2019,(12):1679.
[4]刘昌莲,贺冬冬,李晓明,等.艾拉莫德治疗类风湿关节炎疗效及对患者免疫炎症因子水平和骨代谢指标的影响*[J].陕西医学杂志,2020,49(5):603.
　LIU Changlian,HE Dongdong,LI Xiaoming,et al.Clinical efficacy of Iguratimod in the treatment of rheumatoid arthritis and its effect on the levels of immune inflammatory factors and the indexes of bone metabolism[J].,2020,49(12):603.
[5]刘兆宜,沈洲立,岳跃兵,等.类风湿关节炎并发动脉粥样硬化相关性研究进展*[J].陕西医学杂志,2020,49(11):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
　LIU Zhaoyi,SHEN Zhouli,YUE Yuebing,et al.Research progress on the correlation between rheumatoid arthritis and atherosclerosis[J].,2020,49(12):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
[6]李长超,柴艳梅,刘 丹,等.类风湿关节炎患者血清IL-13水平表达及对外周血单个核细胞中Th17细胞亚群分化的影响[J].陕西医学杂志,2021,50(2):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
　LI Changchao,CHAI Yanmei,LIU Dan,et al.Expression of serum IL-13 in patients with rheumatoid arthritis and its effect on differentiation of Th17 cell subsets in PBMC[J].,2021,50(12):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
[7]安 新,冯 超,高利常.类风湿关节炎患者血清白细胞介素-32、白细胞介素-17和白细胞介素-10表达水平及临床意义[J].陕西医学杂志,2021,50(12):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
　AN Xin,FENG Chao,GAO Lichang.Expression levels of serum interleukin-32,interleukin-17 and interleukin-10 in patients with rheumatoid arthritis and their clinical significance[J].,2021,50(12):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
[8]杨 婧,何家锐,孙红兵,等.沙利度胺对类风湿关节炎滑膜细胞及外周血单个核细胞分泌肿瘤坏死因子-α和血管内皮生长因子的影响及机制研究[J].陕西医学杂志,2022,51(12):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
　YANG Jing,HE Jiarui,SUN Hongbing,et al.Effects of thalidomide on secretion of TNF-α and VEGF in fibroblast-like synoviocytes and peripheral blood mononuclear cells in patients with rheumatoid arthritis and its mechanism[J].,2022,51(12):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
[9]王一晨,谷慧敏,陈宇华,等.孟德尔随机化在类风湿关节炎相关研究中的应用[J].陕西医学杂志,2024,(11):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
　WANG Yichen,GU Huimin,CHEN Yuhua,et al.Application of Mendelian randomization in rheumatoid arthritis-related research[J].,2024,(12):1562.[doi:DOI:10.3969/j.issn.1000-7377.2024.11.027]
[10]康 聪,杨 光,王 芳,等.牛膝多糖调控转移相关蛋白1/核因子-κB通路对类风湿关节炎大鼠踝关节破坏的影响实验研究[J].陕西医学杂志,2024,(12):1624.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.007]
　KANG Cong,YANG Guang,WANG Fang,et al.Effects of achyranthan polysaccharides regulating MTA1/NF-κB pathway on destruction of ankle joint in rats with rheumatoid arthritis[J].,2024,(12):1624.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.007]

备注/Memo

备注/Memo:
基金项目:青海省科技计划项目(2021-SF-136); 白求恩·医学科学研究基金资助项目(TY170BN)
更新日期/Last Update: 2023-12-05